Equities
IndustrialsGeneral Industrials
  • Price (USD)76.67
  • Today's Change0.17 / 0.22%
  • Shares traded1.96m
  • 1 Year change+10.19%
  • Beta1.4093
Data delayed at least 15 minutes, as of Mar 28 2024 20:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

DuPont de Nemours, Inc. provides technology-based materials and solutions. The Company’s segments include Electronics & Industrial and Water & Protection. The Electronics & Industrial segment is a provider of differentiated materials and component solutions for computing, 5G, electric vehicles (EV), a range of consumer electronics, including mobile devices, television monitors, personal computers and a variety of other industries including aerospace, defense, transportation, healthcare, and medical devices. The segment supplies materials and solutions for the fabrication of semiconductors and integrated circuits addressing multiple steps of the manufacturing process. The Water & Protection segment provides engineered products and integrated systems for a number of industries including, worker safety, water purification and separation, transportation, energy, medical packaging and building materials. Its brands include NOMEX, KEVLAR, TYVEK, FILMTEC, AMBERLITE, and STYROFOAM.

  • Revenue in USD (TTM)12.07bn
  • Net income in USD494.00m
  • Incorporated2015
  • Employees24.00k
  • Location
    Dupont De Nemours Inc974 Centre Rd Bldg 730WILMINGTON 19805United StatesUSA
  • Phone+1 (302) 295-5783
  • Fax+1 (302) 655-5049
  • Websitehttps://www.dupont.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
DD:NYQ since
announced
Transaction
value
Spectrum Plastics Group IncDeal completed02 May 202302 May 2023Deal completed10.51%1.75bn
Data delayed at least 15 minutes, as of Mar 28 2024 20:10 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Biomarin Pharmaceutical Inc2.42bn167.65m16.48bn3.40k99.483.3360.586.810.8780.87812.5826.250.36610.51454.42711,327.902.540.77732.930.882578.7276.306.932.241.57--0.180.0015.4210.1618.43---5.74--
Alnylam Pharmaceuticals, Inc.1.83bn-440.24m18.82bn2.10k------10.30-3.59-3.5914.46-1.750.49572.858.43870,615.30-11.94-26.56-15.61-32.7783.0283.66-24.08-94.262.99-2.111.28--76.2389.4561.08---13.29--
ICON PLC8.12bn612.34m27.71bn41.10k45.393.0023.123.417.407.4098.17112.020.4752--2.99197,571.203.593.934.284.8029.6628.917.557.37--3.150.2901--4.8925.6221.1813.6723.79--
Biogen Inc9.84bn1.16bn31.34bn7.57k27.032.1118.923.197.987.9867.67102.140.38271.314.641,299,287.004.5212.535.2014.8374.2481.8411.8126.931.263.860.31920.00-3.32-6.07-61.89-23.58-18.87--
DuPont de Nemours Inc12.07bn494.00m32.02bn24.00k73.931.3619.062.651.040.925626.7756.450.3023.504.94502,833.301.330.37091.480.46835.0835.694.421.971.736.610.2398414.03-7.29-11.79-51.1911.24-30.66-20.59
Gartner Inc5.91bn882.47m37.16bn20.24k43.0854.8634.626.2911.0711.0774.138.690.7805--3.68291,888.9011.668.2422.7414.7667.7867.5514.9412.20--12.010.7832--7.878.249.2449.78-4.06--
Moderna Inc6.85bn-4.71bn40.80bn5.60k--2.94--5.96-12.39-12.3917.6836.270.30938.156.011,222,857.00-21.2920.95-25.9429.5131.47---68.8432.103.36--0.03990.00-64.45119.28-156.37--46.22--
Iqvia Holdings Inc14.98bn1.36bn45.90bn87.00k34.657.5118.493.067.307.3080.4233.670.5761--4.76172,229.905.223.246.804.0734.9634.329.066.03--3.240.69110.003.987.5524.4743.397.17--
Data as of Mar 28 2024. Currency figures normalised to Dupont De Nemours Inc's reporting currency: US Dollar USD

Institutional shareholders

34.05%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Dec 202346.18m11.06%
Massachusetts Financial Services Co.as of 31 Dec 202322.16m5.31%
BlackRock Fund Advisorsas of 31 Dec 202321.07m5.05%
SSgA Funds Management, Inc.as of 31 Dec 202317.17m4.11%
Geode Capital Management LLCas of 31 Dec 20239.55m2.29%
Invesco Advisers, Inc.as of 31 Dec 20236.16m1.47%
Putnam Investment Management LLCas of 31 Dec 20235.20m1.24%
Boston Partners Global Investors, Inc.as of 31 Dec 20235.08m1.22%
Macquarie Investment Management Business Trustas of 31 Dec 20234.92m1.18%
Barrow, Hanley, Mewhinney & Strauss LLCas of 31 Dec 20234.72m1.13%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.